Artivion, Inc. (AORT)

USD 22.46

(-3.27%)

Long Term Debt Summary of Artivion, Inc.

  • Artivion, Inc.'s latest annual long term debt in 2023 was 305.53 Million USD , down -13.05% from previous year.
  • Artivion, Inc.'s latest quarterly long term debt in 2024 Q2 was 313.29 Million USD , up 0.09% from previous quarter.
  • Artivion, Inc. reported annual long term debt of 351.4 Million USD in 2022, down -1.5% from previous year.
  • Artivion, Inc. reported annual long term debt of 356.73 Million USD in 2021, up 15.15% from previous year.
  • Artivion, Inc. reported quarterly long term debt of 313.29 Million USD for 2024 Q2, up 0.09% from previous quarter.
  • Artivion, Inc. reported quarterly long term debt of 349.54 Million USD for 2023 Q2, down -0.31% from previous quarter.

Annual Long Term Debt Chart of Artivion, Inc. (2023 - 1991)

Historical Annual Long Term Debt of Artivion, Inc. (2023 - 1991)

Year Long Term Debt Long Term Debt Growth
2023 305.53 Million USD -13.05%
2022 351.4 Million USD -1.5%
2021 356.73 Million USD 15.15%
2020 309.8 Million USD 30.22%
2019 237.9 Million USD 7.33%
2018 221.65 Million USD -1.53%
2017 225.09 Million USD 235.9%
2016 67.01 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD -100.0%
2009 315 Thousand USD 0.0%
2008 315 Thousand USD 288.89%
2007 81 Thousand USD -34.68%
2006 124 Thousand USD 0.0%
2005 - USD -100.0%
2004 530 Thousand USD -29.43%
2003 751 Thousand USD -22.66%
2002 971 Thousand USD -88.89%
2001 8.74 Million USD -26.59%
2000 11.9 Million USD 92.73%
1999 6.17 Million USD -6.41%
1998 6.6 Million USD -60.95%
1997 16.9 Million USD 503.57%
1996 2.8 Million USD 0.0%
1995 - USD 0.0%
1994 - USD 0.0%
1993 - USD -100.0%
1992 800 Thousand USD 166.67%
1991 300 Thousand USD 0.0%

Peer Long Term Debt Comparison of Artivion, Inc.

Name Long Term Debt Long Term Debt Difference
Abbott Laboratories 13.59 Billion USD 97.753%
Allurion Technologies Inc. 2.3 Million USD -13149.393%
Avanos Medical, Inc. 159.4 Million USD -91.676%
Butterfly Network, Inc. 22.83 Million USD -1237.994%
Butterfly Network, Inc. 22.83 Million USD -1237.994%
Bio-Rad Laboratories, Inc. 1.18 Billion USD 74.313%
Boston Scientific Corporation 8.96 Billion USD 96.59%
CONMED Corporation 971.48 Million USD 68.55%
Edwards Lifesciences Corporation 670 Million USD 54.398%
Paragon 28, Inc. 109.79 Million USD -178.264%
Glaukos Corporation 383.73 Million USD 20.38%
Globus Medical, Inc. 417.4 Million USD 26.801%
Inspire Medical Systems, Inc. 24.84 Million USD -1129.699%
Integer Holdings Corporation 959.92 Million USD 68.171%
Medtronic plc 23.87 Billion USD 98.72%
Myomo, Inc. 115.16 Thousand USD -265210.003%
Nevro Corp. 211.47 Million USD -44.479%
Owlet, Inc. 22 Thousand USD -1388677.273%
Penumbra, Inc. 220.9 Million USD -38.306%
Vicarious Surgical Inc. 13.78 Million USD -2116.402%
Smith & Nephew plc 2.17 Billion USD 85.953%
Sonendo, Inc. 14.03 Million USD -2076.922%
STERIS plc 3.12 Billion USD 90.208%
Stryker Corporation 10.9 Billion USD 97.197%
Vapotherm, Inc. 109.97 Million USD -177.811%
Zimmer Biomet Holdings, Inc. 4.86 Billion USD 93.724%